Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NCI-Funded Research at the 2024 San Antonio Breast Cancer Symposium December 10-13

Date Posted

For those participating in the 2024 Symposium, consider attending these sessions to learn about the latest from DCP-funded research from NCORP and the Grand Challenges Program.

Check out the full online program: https://sabcs.org/FullProgram

Wednesday December 11, 12:30 PM CT

Poster Session 1

Location: Halls 2-3
P1-01-05: Conducting Ancillary Studies during an Active NCTN/NCORP Screening Trial – The TMIST (ECOG-ACRIN EA1151) Experience
Presenter: Etta Pisano

Wednesday December 11, 5:30 PM CT

Poster Session 2

Location: Halls 2-3
P2-01-07: The Co-Occurrence of Obesity and Cancer-Related Fatigue and Their Combined Impact on Physical Function in a Nationwide RCT of 456 Breast Cancer Survivors (a URCC NCORP Study).
Presenter: Lindsey Mattick

Thursday December 12, 8:30 – 9:00 AM CT

Plenary Lecture

Location: Hall 1
Moderator: Virginia Kaklamani, UT Health Mays Cancer Center, San Antonio, Texas

The Grand Challenge of Unraveling Social vs Biological Drivers of Racial Disparities in Cancer Outcomes

Presenter: Melissa B. Davis, Morehouse School of Medicine, Atlanta, Georgia Cancer Grand Challenge

Thursday December 12, 9:00 – 11:45 AM CT

General Session 2

Location: Hall 1
GS2-02: Impact of Tamoxifen Only after Breast Conservation Surgery for "Good Risk" Duct Carcinoma in Situ: Results from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trial
Presenter: Jean Wright, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Thursday December 12, 12:00 PM CT

Rapid Fire 2

Location: Hall 1
RF2-06: A Nationwide Double-Blind Phase III RCT Comparing Olanzapine and Prochlorperazine for Refractory Chemotherapy-Induced Nausea in NCORP Community Practices
Presenter: Luke Peppone, University of Rochester Medical Center, Rochester, New York

Friday December 13, 12:00 – 12:55 PM CT

Rapid Fire 3

Location: Hall 1
RF3-06: Mepitel Film for the Reduction of Radiation Dermatitis in Postmastectomy Radiation Therapy: Results from Alliance A221803: A Multicenter Phase III Randomized Clinical Trial
Presenter: Kimberly Corbin, Mayo Clinic, Rochester, Minnesota

Friday December 13, 12:30 – 1:45 PM CT

Roundtable discussion: Risk Reduction and Early Detection: New Directions in Breast Cancer Prevention

Location: Stars at Night 3-4
Moderator: Gretchen Gierach, National Cancer Institute, Bethesda, Maryland

Can We Use Biomarkers to Implement Prevention?

Presenter: Seema Khan, Feinberg School of Medicine of Northwestern University, Chicago, Illinois